R-citalopram attenuates anxiolytic effects of escitalopram in a rat ultrasonic vocalisation model

被引:47
作者
Sánchez, C [1 ]
机构
[1] H Lundbeck & Co AS, Neuropharmacol Res, DK-2500 Copenhagen, Denmark
关键词
5-HT; (5-hydroxytryptamine; serotonin); anxiolytic; citalopram; escitalopram; R-citalopram;
D O I
10.1016/S0014-2999(03)01376-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Escitalopram mediates the serotonin reuptake inhibitory effect of citalopram. To investigate the potential interactive effects between escitalopram and R-citalopram, they were studied at standard and elevated serotonin levels in a model predictive of anxiolytic activity (inhibition of footshock-induced ultrasonic vocalisation in adult rats). At standard levels, citalopram partially inhibited (64%) and escitalopram abolished (97%) vocalisation. Co-treatment with L-5-hydroxytryptophan resulted in complete inhibition with citalopram and a substantially enhanced response to escitalopram, while R-citalopram increased the vocalisation significantly. Furthermore, R-citallopram attenuated the effect of escitalopram. These findings may be relevant to the enhanced clinical efficacy seen with escitalopram compared to citalopram. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:155 / 158
页数:4
相关论文
共 14 条
[11]  
SANCHEZ C, 2003, IN PRESS PSYCHOPHARM
[12]  
SANCHEZ C, 2003, IN PRESS EUR J PHARM
[13]   Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care [J].
Wade, A ;
Lemming, OM ;
Hedegaard, KB .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2002, 17 (03) :95-102
[14]  
Wiborg O, 2002, EUR NEUROPSYCHOPHARM, V12, pS229